ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
GSK at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
GSK takes part in 4 sessions at ESMO 2026 in Madrid, and exhibits at Booth 1023. Its program centres on treatment and survival in endometrial and ovarian cancers, alongside drug discovery. It covers long-term survival and a drug designed to target multiple mutations in gastrointestinal stromal tumours.
| Organization | ESMO 2026 Attendance |
|---|---|
British pharmaceutical company whose oncology medicines include niraparib, dostarlimab and momelotinib. | Booth Exhibiting at Booth 1023 Satellite Fri Oct 23 18:15–19:45 Satellite Sat Oct 24 13:00–14:30 GSK - From Discovery to Impact: ADCs in Endometrial and Ovarian Cancer Care Gynaecological cancers Talk Mon Oct 26 11:05–11:30 Poster Mon Oct 26 12:00–12:45 |
Find decision makers at GSK
Tell us what you sell and we’ll find the people at GSK most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction